Related Experiment Video

Updated: Jan 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K

Implementing Dyslipidemia Guidelines into Clinical Practice Following an Acute Coronary Syndrome: Challenges and

Alisha Labinaz1, Ren Jie Robert Yao1, Farshad Hosseini1

  • 1Division of Cardiology, Department of Medicine, and the Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, British Columbia, Canada.

CJC Open
|December 22, 2025
PubMed

Insights

Patients with acute coronary syndrome (ACS) need better lipid management for secondary prevention. Improving follow-up care, particularly through dedicated clinics, can help patients reach cholesterol targets and reduce cardiovascular event risk.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Lipidology

Background:

  • Patients with acute coronary syndrome (ACS) face a persistent risk of cardiovascular events.
  • Secondary prevention, including dyslipidemia management, is crucial for post-ACS care.
  • Lipid-lowering therapies effectively reduce low-density lipoprotein cholesterol (LDL-C), a key risk factor.

Purpose of the Study:

  • To review strategies for optimizing lipid management in patients after ACS.
  • To highlight the underutilization of guideline-recommended LDL-C targets and therapy intensification.
  • To assess the potential of standardized follow-up care, such as dedicated post-ACS clinics.

Main Methods:

  • Review of randomized controlled trials and registry data.
  • Analysis of current practices in post-ACS lipid management.
  • Assessment of strategies for improving patient outcomes.

Main Results:

  • Despite proven benefits of lipid-lowering therapies, many post-ACS patients do not achieve target LDL-C levels.
  • Intensification of lipid-lowering therapy is underutilized in this population.
  • Dedicated post-ACS clinics offer a potential model for standardized care.

Conclusions:

  • Enhanced strategies are needed to improve lipid management post-ACS.
  • Standardizing follow-up care through dedicated clinics may improve adherence and outcomes.
  • Optimizing dyslipidemia management is essential for secondary prevention in ACS survivors.

Keywords:
Dyslipidemiaacute coronary syndromelipid lowering therapiespost acute coronary syndrome clinicssecondary prevention

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325